About SOFIE
SOFIE is a Healthcare company based in Culver City (United States) founded in 2008, and was acquired by GE Healthcare in October 2026. Developer of molecular imaging systems and radio-pharmaceuticals. SOFIE has raised $43.1 million across 13 funding rounds from investors including GE Healthcare, DOE and National Cancer Institute. The company has 546 employees. SOFIE has completed 1 acquisition, including Zevacor. Its chief executive, as recorded, is Patrick Phelps. SOFIE offers products and services including Tracers, Contract Manufacturing, and Education Programs. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is SOFIE Biosciences. Its competitors include Mariana Oncology, ARTBIO and Lantheus; 2 of its 3 listed competitors have raised funding.
Company details
Sofie Biosciences is developing molecular imaging systems and radio-pharmaceuticals. The companys molecular imaging device uses positron emission tomography (PET). Its other products include radiochemistry synthesizers, small animal PET imaging cameras, PET probes. The companys products are used for diagnosis, staging, and treatment evaluation in oncology, neurology, cardiology, and immunology.
- Total Equity Funding$43.1M (USD)
in 13 rounds
- InvestorsGE Healthcare
& 7 more
- Employee Count546
- Investments & Acquisitions
- Acquired byGE Healthcare
(Oct 2026)
Products & Services of SOFIE
SOFIE offers a comprehensive portfolio of products and services, including Tracers, Contract Manufacturing, and Education Programs.
Products for molecular imaging and diagnostics in patients.
Manufacturing services for clinical radiopharmaceutical needs.
Programs to enhance PET technology and patient care.
Funding Insights of SOFIE
SOFIE has successfully raised a total of $43.1M across 13 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.1M
- Total Rounds 13
- First Round $2M
(Nov 2010)
- Investors Count 7
Latest 10 of 13 funding rounds of SOFIE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | Private Equity Round | – | Trilantic Capital Partners North America | – | |
| Nov 2020 | $27.4M | Series C | – | Jubilant Pharma | – |
| Sep 2017 | $2M | Grant | – | – | |
| Sep 2016 | $1.18M | Grant | – | – | |
| Jun 2016 | $3.7M | Series A | – | – | – |
| Oct 2014 | $1.5M | Grant | – | – | |
| Nov 2013 | $5M | Series A | – | – | |
| Oct 2013 | $5M | Series A | – | – | |
| Apr 2012 | $3.92M | Grant | – | – | |
| Jul 2011 | Grant | – | – |
8 investors in total: 8 institutional.
Investors in SOFIE
SOFIE has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include GE Healthcare, DOE and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage agnostic VC firm investing primarily in the US | cycadvc.com | Santa Barbara, United States | ||
Private equity investments are targeted at North American companies. | trilanticnorthamerica.com | New York, United States | ||
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States | ||
Cancer research is conducted and supported by the institute. | cancer.gov | Bethesda, United States | ||
Manages a real estate fund focused on value-added investments in retail properties. | 2011 | mrmcapitalllc.com | ||
Energy sources and policies are managed by the DOE. | 1977 | energy.gov | ||
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | 1978 | jubilantpharma.com | Noida, India | |
Materials management solutions are provided for healthcare organizations. | 1892 | gehealthcare.com | Chicago, United States |
Investor details for SOFIE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SOFIE
63 people are tracked at SOFIE (26 in leadership, 11 in board & advisors, 26 in team); the tracked headcount is 546.
| Name | Role | Group |
|---|---|---|
Patrick Phelps | CEO & President | Leadership |
Stephanie Mann | Chief Financial Officer | Leadership |
Philipp Czernin | Chief Business Officer | Leadership |
Brian Schumer | COO | Leadership |
Cristen Brown | VP, Quality | Leadership |
Sherly Mosessian | Chief Scientific Officer | Leadership |
Brad Knorr | Director Cyclotron Services | Leadership |
Glenn Jennings | Senior Director Quality, Radiopharmaceutical Contract Manufacturing | Leadership |
Kirk McCall | Regional Operations Director | Leadership |
Hilary L. | Sr. Director, Quality Management & Sterility Assurance | Leadership |
Steven Ross | Director Of Business Systems | Leadership |
William Crisp | Vice President Operations | Leadership |
Dave Shawkey | Director Of Procurement | Leadership |
Sean Murphy | Sr. Director Of Strategy | Leadership |
Jeffrey Danklefsen | Director, Facility Operations | Leadership |
Laura Crandall-Carney | Director, Quality Management, Partners & Training | Leadership |
John Dougherty | Director, Quality Management | Leadership |
Mark A. Juarez | Regional Director, Operation- Western/southern US | Leadership |
Jerrod Brown | Regional Director Of Operations | Leadership |
Micah Bounds | Regional Director Of Operations | Leadership |
43 more people are available in the full profile.
Complete people profiles for SOFIE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SOFIE
SOFIE has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Zevacor.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Radiolabeling & radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging | zevacor.com | Dulles, United States | 2013 | Sep 2017 | •••• |
Complete acquisition details for SOFIE
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SOFIE
5 dated milestones of SOFIE across 18 years, from founding to its latest funding, stage changes and deals.
- Founded SOFIE is founded.
- Funding First funding round of $2.0M.
- Acquisition Acquires Zevacor.
- Funding Latest funding round, Private Equity Round,.
- Exit Acquired by GE Healthcare.
Competitors of SOFIE
SOFIE has 3 listed competitors in our database, 2 of them funded. They include Mariana Oncology, ARTBIO and Lantheus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| marianaoncology.com | 2020 | Watertown, United States | $250M | 41 | Targeted radiopharmaceuticals for solid tumors are developed and pioneered. | |
| artbio.com | 2021 | Sacramento, United States | $245.3M | Alpha radioligand therapies for cancer are developed using lead-212. | ||
| lantheus.com | 2008 | Billerica, United States | 834 | Developer of diagnostic imaging agents and targeted therapeutics |
Detailed competitors of SOFIE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SOFIE
The website of SOFIE (sofie.com) receives about 5.2K visits a month.
- Monthly visits5.2K
▼ 4.5% vs previous month
Websites whose visitors overlap most with SOFIE. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| trilanticnorthamerica.com | 100% | #3,400,807 | View details |
Top companies in Oncology
3 companies that operate in the same segment as SOFIE (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sofie
Complete news archive for SOFIE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SOFIE
SOFIE was founded in 2008 and raised its 1st funding round 2 years after it was founded.
SOFIE is headquartered in Culver City, United States. It is registered at Culver City, California, United States.
Patrick Phelps is the CEO of SOFIE, as recorded in our data.
SOFIE is a funded company, having raised a total of $43.1M across 13 funding rounds to date.
SOFIE has 546 employees.
Sofie Biosciences is developing molecular imaging systems and radio-pharmaceuticals. The companys molecular imaging device uses positron emission tomography (PET). Its other products include radiochemistry synthesizers, small animal PET imaging cameras, PET probes. The companys products are used for diagnosis, staging, and treatment evaluation in oncology, neurology, cardiology, and immunology.
SOFIE's top competitors include Mariana Oncology, Lantheus and ARTBIO.
SOFIE offers Tracers, Contract Manufacturing, and Education Programs.
SOFIE has made 1 acquisition, including Zevacor.
SOFIE has 8 investors. Key investors include GE Healthcare, DOE, National Cancer Institute, Jubilant Pharma, and OSTI.GOV.
SOFIE operates through Sofie Biosciences.
Yes. SOFIE was acquired by GE Healthcare in October 2026.